210 related articles for article (PubMed ID: 31725897)
1. Haematopoietic stem cell reprogramming and the hope for a universal blood product.
Barcia Durán JG; Lis R; Rafii S
FEBS Lett; 2019 Dec; 593(23):3253-3265. PubMed ID: 31725897
[TBL] [Abstract][Full Text] [Related]
2. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
Chen Y; Yi Y; Xu J; Chan WK; Loh YH
FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
[TBL] [Abstract][Full Text] [Related]
3. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
4. Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate.
Wahlestedt M; Erlandsson E; Kristiansen T; Lu R; Brakebusch C; Weissman IL; Yuan J; Martin-Gonzalez J; Bryder D
Nat Commun; 2017 Feb; 8():14533. PubMed ID: 28224997
[TBL] [Abstract][Full Text] [Related]
5. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.
Ferreira AF; Calin GA; Picanço-Castro V; Kashima S; Covas DT; de Castro FA
J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29467236
[TBL] [Abstract][Full Text] [Related]
7. Conversion of adult endothelium to immunocompetent haematopoietic stem cells.
Lis R; Karrasch CC; Poulos MG; Kunar B; Redmond D; Duran JGB; Badwe CR; Schachterle W; Ginsberg M; Xiang J; Tabrizi AR; Shido K; Rosenwaks Z; Elemento O; Speck NA; Butler JM; Scandura JM; Rafii S
Nature; 2017 May; 545(7655):439-445. PubMed ID: 28514438
[TBL] [Abstract][Full Text] [Related]
8. An Insight into Reprogramming Barriers to iPSC Generation.
Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
[TBL] [Abstract][Full Text] [Related]
10. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
[TBL] [Abstract][Full Text] [Related]
11. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
12. Engineered Murine HSCs Reconstitute Multi-lineage Hematopoiesis and Adaptive Immunity.
Lu YF; Cahan P; Ross S; Sahalie J; Sousa PM; Hadland BK; Cai W; Serrao E; Engelman AN; Bernstein ID; Daley GQ
Cell Rep; 2016 Dec; 17(12):3178-3192. PubMed ID: 28009288
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming.
Kang L; Wu J; Tao Y; Li H; Liu X; Gao S; Wang QF
Stem Cells Dev; 2015 Jun; 24(12):1483-92. PubMed ID: 25751301
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction.
Sandler VM; Lis R; Liu Y; Kedem A; James D; Elemento O; Butler JM; Scandura JM; Rafii S
Nature; 2014 Jul; 511(7509):312-8. PubMed ID: 25030167
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic stem and progenitor cells from human pluripotent stem cells.
Sugimura R; Jha DK; Han A; Soria-Valles C; da Rocha EL; Lu YF; Goettel JA; Serrao E; Rowe RG; Malleshaiah M; Wong I; Sousa P; Zhu TN; Ditadi A; Keller G; Engelman AN; Snapper SB; Doulatov S; Daley GQ
Nature; 2017 May; 545(7655):432-438. PubMed ID: 28514439
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of haematopoietic stem cells.
Wilkinson AC; Göttgens B
Adv Exp Med Biol; 2013; 786():187-212. PubMed ID: 23696358
[TBL] [Abstract][Full Text] [Related]
18. Resolving Cell Fate Decisions during Somatic Cell Reprogramming by Single-Cell RNA-Seq.
Guo L; Lin L; Wang X; Gao M; Cao S; Mai Y; Wu F; Kuang J; Liu H; Yang J; Chu S; Song H; Li D; Liu Y; Wu K; Liu J; Wang J; Pan G; Hutchins AP; Liu J; Pei D; Chen J
Mol Cell; 2019 Feb; 73(4):815-829.e7. PubMed ID: 30772174
[TBL] [Abstract][Full Text] [Related]
19. Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming.
Daniel MG; Lemischka IR; Moore K
Ann N Y Acad Sci; 2016 Apr; 1370(1):24-35. PubMed ID: 26748878
[TBL] [Abstract][Full Text] [Related]
20. Linking Hematopoietic Differentiation to Co-Expressed Sets of Pluripotency-Associated and Imprinted Genes and to Regulatory microRNA-Transcription Factor Motifs.
Hamed M; Trumm J; Spaniol C; Sethi R; Irhimeh MR; Fuellen G; Paulsen M; Helms V
PLoS One; 2017; 12(1):e0166852. PubMed ID: 28052084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
